HC-LITT to Provide Stabilization Technology to the Harvard Research Community
News Apr 24, 2009
Denator AB announced an agreement with Harvard Catalyst - Laboratory for Innovative Translational Technologies (HC-LITT) at Harvard Catalyst | The Harvard Clinical and Translational Science Center that will give the Harvard research community access to the company’s Stabilizor™ system for stabilizing biological samples.
HC-LITT was established to enable researchers to bridge the "innovation gap" between academia and industry. A central component of Harvard Catalyst, a primary goal of HC-LITT is to provide the Harvard research community with early access to new, enabling, LITT hope to accelerate the translation of laboratory research in therapeutics and diagnostics into the clinic.
HC-LITT Director Winston Patrick Kuo DMSc, DDS, says: “Denator’s rapid heat inactivation technology, Stabilizor T1, which stabilizes tissues instantly and ensures that this stability is maintained during downstream analyses, nicely complements the set of downstream technologies currently used at HC-LITT and local proteomic core facilities. We are very pleased to include the instrument in our suite of enabling leading-edge genomic and proteomic technologies. This new approach is expected to have a large impact on sample preparation and handling in the future.”
Denator’s first commercial system for tissue stabilization was launched at the HUPO meeting in Amsterdam in August, 2008.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018